H.C. Wainwright and Co. Revenue and Competitors

USA

Location

N/A

Total Funding

Banking

Industry

Estimated Revenue & Valuation

  • H.C. Wainwright and Co.'s estimated annual revenue is currently $27.7M per year.(i)
  • H.C. Wainwright and Co.'s estimated revenue per employee is $208,421

Employee Data

  • H.C. Wainwright and Co. has 133 Employees.(i)
  • H.C. Wainwright and Co. grew their employee count by 13% last year.

H.C. Wainwright and Co.'s People

NameTitleEmail/Phone
1
Equity Research VPReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Chief Compliance OfficerReveal Email/Phone
4
Managing DirectorReveal Email/Phone
5
Equity Capital MarketsReveal Email/Phone
6
Senior Equity Research AnalystReveal Email/Phone
7
Human Resources Coordinator, Executive AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.4M50-9%N/AN/A
#2
$45.5M1855%N/AN/A
#3
$276.7M941-10%N/AN/A
#4
$18.9M9823%N/AN/A
#5
$14.2M7514%N/AN/A
#6
$7.6M37-7%N/AN/A
#7
$23.7M11316%N/AN/A
#8
$82.4M309-1%$20MN/A
#9
$90.7M340-10%$4.1MN/A
#10
$22.5M107-43%$19MN/A
Add Company

What Is H.C. Wainwright and Co.?

H. C. Wainwright & Co., LLC is a full-service investment bank dedicated to providing Investment Banking, Equity Research, Sales & Trading as well Corporate Access and Strategic Advisory services.\n \nRanked the #1 Placement Agent by Informa Business Solutions (formerly Sagient Research Systems) since 1998, the H.C. Wainwright team is the leader and most active placement agent of Follow-On transactions.\n \nIn 2018, H.C. Wainwright celebrates 150 years of innovative service led by a diverse group of seasoned Investment Bankers, thoughtful Equity Research Analysts and insightful Sales-Traders.

keywords:N/A

N/A

Total Funding

133

Number of Employees

$27.7M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

H.C. Wainwright and Co. News

2022-04-20 - NKTX stock slips stock offering H.C. Wainwright cheers study ...

H.C. Wainwright has increased its price target on the clinical-stage biotech Nkarta (NASDAQ:NKTX) on Tuesday to reflect the prospects of its...

2022-04-20 - Gossamer stock falls 12% as HC Wainwright/Barclays cut ...

H.C. Wainwright analyst Patrick Trucchio lowered the firm's price target on Gossamer to $20 from $25 and kept a Buy rating on the shares.

2022-04-17 - Read Why HC Wainwright Cut Price Target For Dentsply Sirona - Benzinga

HC Wainwright's estimated adjusted EPS (from 1Q22 to 4Q22) drops to $2.62 from $3.14, and the 2022 revenue projection decreases to $4.153...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.6M133N/AN/A
#2
$19.3M1337%N/A
#3
$20M133N/AN/A
#4
$32.6M13313%N/A
#5
$50.2M1332%N/A